[The effect on sexuality of cyproterone acetate].
D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists; D002369:Castration; D002986:Clinical Trials as Topic; D003534:Cyproterone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use; D005860:Germany, West; D006062:Gonadotropins / Q000037:antagonists & inhibitors; D006716:Homosexuality / Q000188:drug therapy; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D007989:Libido / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D010262:Paraphilic Disorders / Q000188:drug therapy*; D010554:Personality Disorders / Q000188:drug therapy; D011372:Progestins / Q000037:antagonists & inhibitors; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy; D012742:Sex Offenses
D000726:Androgen Antagonists; D004967:Estrogens; D006062:Gonadotropins; D011372:Progestins; D003534:Cyproterone
Erfahrunger über die Beeinflussung der Sexualität durch Cyproteronacetat